China NT Pharma Group Co., Ltd. (HK:1011) has released an update.
China NT Pharma Group Co. Ltd. has announced a clarification on its share consolidation plan, stating a ten-to-one consolidation of its existing shares and convertible preference shares. The company’s authorized capital will remain unchanged at US$50,100, but the number of shares will be reduced proportionally. This adjustment includes the alteration of the board lot size and the corresponding adjustments to the outstanding share options.
For further insights into HK:1011 stock, check out TipRanks’ Stock Analysis page.
